Pfizer Vaccine for Young Children: FDA Review Fuels Controversy Amidst Political Donations and Doubts
According to an email, the FDA may not renew Pfizer’s pediatric Covid vaccine authorization for the upcoming respiratory season, potentially removing the only vaccine for children under five. This decision would necessitate Moderna to increase its supply, although its vaccine is currently only approved for children with specific health conditions. The CDC is actively engaged in discussions with Moderna, focusing on addressing possible supply gaps and ensuring availability. This development occurs amid already low vaccination rates for children and ongoing concerns about the long-term effects of Covid.
John Q. Hosedrinker